Dimeric structures of quinol-dependent nitric oxide reductases (qNORs) revealed by cryo–electron microscopy by Gopalasingam, GC et al.
Gopalasingam et al., Sci. Adv. 2019; 5 : eaax1803     28 August 2019
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
1 of 11
B I O C H E M I S T R Y
Dimeric structures of quinol-dependent nitric oxide 
reductases (qNORs) revealed by  
cryo–electron microscopy
Chai C. Gopalasingam1, Rachel M. Johnson2,3, George N. Chiduza1, Takehiko Tosha4, 
Masaki Yamamoto4, Yoshitsugu Shiro5, Svetlana V. Antonyuk1,  
Stephen P. Muench2,3, S. Samar Hasnain1*
Quinol-dependent nitric oxide reductases (qNORs) are membrane-integrated, iron-containing enzymes of the 
denitrification pathway, which catalyze the reduction of nitric oxide (NO) to the major ozone destroying gas 
nitrous oxide (N2O). Cryo–electron microscopy structures of active qNOR from Alcaligenes xylosoxidans and an 
activity-enhancing mutant have been determined to be at local resolutions of 3.7 and 3.2 Å, respectively. They 
unexpectedly reveal a dimeric conformation (also confirmed for qNOR from Neisseria meningitidis) and define the 
active-site configuration, with a clear water channel from the cytoplasm. Structure-based mutagenesis has 
identified key residues involved in proton transport and substrate delivery to the active site of qNORs. The proton 
supply direction differs from cytochrome c–dependent NOR (cNOR), where water molecules from the cytoplasm 
serve as a proton source similar to those from cytochrome c oxidase.
INTRODUCTION
Bacterial nitric oxide reductases (NORs) are membrane-integrated, 
iron-containing enzymes that are involved in microbial denitrification, 
where soluble nitrogen oxides (e.g., nitrate) are sequentially reduced 
to liberate nitrogen (N2) into the atmosphere (1). NORs catalyze 
the reduction of two molecules of nitric oxide (NO) to nitrous 
oxide (N2O), using two protons and two electrons to cleave the 
N─O bond and concurrent N─N bond formation (2, 3): 2NO + 2H+ + 
2e− → N2O + H2O. NORs are part of the heme-copper oxidase 
superfamily (HCO) (4) and are composed of two subdivisions 
based on their electron donor: cytochrome c–dependent NOR 
(cNOR) and quinol- dependent NOR (qNOR). cNORs have been 
extensively studied and consist of a complex of NorB and NorC, 
with the latter subunit containing heme c that acts as the electron 
donor to the binuclear center consisting of a high-spin heme b3 
and a nonheme iron (FeB) in NorB (3, 5). Because oxygen-reducing 
HCO members (like cytochrome c oxidase) create a proton electro-
chemical gradient by pumping protons across the membrane 
(and by taking protons from the negative phase) (6, 7), it was 
unexpected to find that with cNORs, the protons were taken up 
from the periplasmic side, indicating a non-electrogenic reaction 
(8–10).
In contrast, qNORs are single subunit enzymes (NorZ), in which 
electrons are supplied by menaquinol. qNORs are found not only in 
denitrifying organisms but also in various pathogenic species 
(3,11,12), many of which lack the full denitrifying apparatus, bringing 
to attention the role of qNORs in detoxification. NO has long been 
identified as a key signaling molecule, playing an important part in 
smooth muscle relaxation (13) and blood vessel dilation (14). NO is 
also produced in macrophages upon response to infectious agents 
(15), and Neisseria meningitidis shows depleted survival in naso-
pharyngeal tissue when qNOR is knocked out (11). NO is known to 
inhibit several metalloenzymes within bacteria, such as aconitase (16) 
and NADH (reduced form of nicotinamide adenine dinucleotide) 
dehydrogenase (17), and therefore, the presence of qNOR in 
nondenitrifying organisms seems to be that of defense rather than 
energy conservation. Thus, substantial efforts have been put toward 
structural analysis, where the x-ray crystal structure of qNOR from the 
thermophile Geobacillus stearothermophilus (GsqNOR) is determined 
to a resolution of 2.5 Å, revealing a monomeric structure and 
indicating the presence of an ordered water channel toward the 
binuclear center from the cytoplasmic side (18). It has been suggested 
that the water channel acts in tandem with protonable residues to 
provide a proton-conducting channel toward the binuclear center, 
akin to the evolutionarily related K pathway of cytochrome c oxi-
dases (19). However, the incorporation of a non-native zinc at the 
nonheme catalytic iron site rendered the enzyme inactive. qNOR 
from N. meningitidis (NmqNOR) yielded an active enzyme, but its 
crystallographic structure showing a monomer could only be determined 
at a relatively low resolution of ~4.5 Å, where most of the side-chain 
configurations could not be defined (20).
Despite the fact that the subunit composition of cNOR and 
qNOR is different, there are conserved structural similarities. The 
NorB portion of cNOR is homologous to the C terminus of qNOR, 
and although it lacks heme c in the hydrophilic region, it retains a 
similar fold to the NorC subunit of cNOR. Both share a low-spin 
heme b and a high-spin heme b3, with a calcium ion bridging the 
propionates of the respective heme groups, akin to the phylogenetically 
related cbb3 oxidase (21). This apparent structural similarity does 
not extend to either the electron source or the provision of protons 
required for catalysis. It is hypothesized that qNORs may act in a 
similar manner to the bd-type quinol oxidase (22), where proton 
1Molecular Biophysics Group, Institute of Integrative Biology, Faculty of Health and 
Life Sciences, University of Liverpool, Liverpool L69 7ZB, UK. 2School of Biomedical 
Sciences, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK. 
3Astbury Centre for Structural and Molecular Biology, University of Leeds, Leeds 
LS2 9JT, UK. 4RIKEN SPring-8 Center, 1-1-1 Kouto, Sayo, Hyogo 679-5148, Japan. 
5Graduate School of Life Science, University of Hyogo, 3-2-1 Kouto, Kamigori, Ako, 
Hyogo 678-1297, Japan.
*Corresponding author. Email: s.s.hasnain@liv.ac.uk
Copyright © 2019 
The Authors, some 
rights reserved; 
exclusive licensee 
American Association 
for the Advancement 
of Science. No claim to 
original U.S. Government 
Works. Distributed 
under a Creative 
Commons Attribution 
License 4.0 (CC BY).
 o
n
 Septem
ber 6, 2019
http://advances.sciencem
ag.org/
D
ow
nloaded from
 
Gopalasingam et al., Sci. Adv. 2019; 5 : eaax1803     28 August 2019
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
2 of 11
transfer from the cytoplasmic side is coupled to quinol oxidation 
(proton release) to the outside of the membrane.
We have purified highly active qNOR from Alcaligenes xylosoxidans 
(AxqNOR), a Gram-negative -proteobacterium that is equipped with 
denitrification enzymes, in line with its role as an environmental 
organism found in well water and moist soil (23). A. xylosoxidans is 
considered an opportunistic pathogen and has been implicated in 
nosocomial infections (24, 25), is found in patients with cystic fibrosis 
(26), and is also thought to be a multidrug-resistant organism 
(26, 27). Here, we have used these preparations to obtain high-resolution 
structures for the functional wild-type qNOR and its activity-enhanced 
mutant (Val495Ala) by single-particle cryo–electron microscopy 
(cryo-EM) to local resolutions of 3.7 and 3.2 Å, respectively. Cryo-EM 
structures unexpectedly revealed AxqNOR to be a dimer. We thus 
determined a low-resolution (9 Å) cryo-EM structure of active 
NmqNOR, which is also revealed as a dimer establishing the functional 
unit of qNORs. A structure-guided mutational study of AxqNOR 
has allowed us to identify key residues that control and regulate 
proton and substrate access and thus catalysis.
RESULTS
Cryo-EM structural determination of AxqNOR
We explored the structural determination of AxqNOR by single-particle 
cryo-EM, given the recent achievements in solving sub–100-kDa 
membrane protein complexes (28, 29). Although AxqNOR preparations 
had shown a monomer-dimer equilibrium similar to other qNORs, 
as crystallographic structures of GsqNOR and NmqNOR had revealed 
them to be monomers [molecular weight (MW), ~85 kDa], it was 
considered that the AxqNOR monomer on its own would be relatively 
small for a high-resolution EM structure determination. To facilitate 
the cryo-EM structural analysis of AxqNOR, we prepared fusion partner 
constructs to increase the MW of the monomer (96 kDa) to help 
with the alignment of particles during processing. Guided by information 
from protein disorder servers, we truncated the C terminus of 
AxqNOR and fused several different fusion partners for expression 
trials. AxqNOR fused with apocytochrome b562 [BRIL (30)], AxqNOR- 
BRIL, yielded membrane fractions with high NO consumption rates 
relative to the total protein content and was chosen for structural 
studies. Purified AxqNOR-BRIL showed a similar NO consumption 
to wild-type AxqNOR (284 ± 14 versus 291 ± 6 mol NO min−1 
mol−1 qNOR). An exploratory cryo-EM dataset revealed that the 
particles had a preference toward the carbon edges, with only a low 
level of clumping present. This likely reflects the “halo” effect that 
some detergent-solubilized samples exhibit upon freezing, where 
thinner ice is observed in the center of the hole and becomes thicker 
toward the edge (31). A small test dataset of ~1200 micrographs 
produced an initial ~7 Å reconstruction, revealing a previously 
unseen dimeric form of the protein. Subsequently, a larger dataset 
(3213 micrographs) was collected thereafter (table S1), of which the 
particles produced two-dimensional (2D) class averages with visible 
secondary structure elements, showing a dimeric AxqNOR enveloped 
by a large micelle. The BRIL portion was less clear, possibly due to 
its flexibility. Note that no monomeric qNOR classes could be 
generated from the large particle set, highlighting the fact that the 
samples are dominated by the dimeric species. Data were processed, 
with C2 symmetry imposed, providing a structure with a global 
resolution of 3.9 Å [estimated using the gold standard Fourier shell 
correlation (FSC) = 0.143 criterion (32)], where local resolution 
valued the core of the protein calculated at 3.7 Å. Because the BRIL 
density was at significantly lower resolution, it was omitted during 
model building, leaving just the AxqNOR model.
The dimeric AxqNOR is related by a twofold symmetry axis and 
exhibits a similar overall structure to those of other qNORs, with 14 
transmembrane helices (TMHs) and an -helical hydrophilic region 
(Fig. 1A). The heme b3 and FeB ligating ligands are present on TMHVIII, 
TMHIX, and TMHXII, where the heme b ligands are present on 
TMHXII and TMHIV (Fig. 1B). The map showed helix pitches and 
density for bulky side chains, consistent with the estimated resolution, 
with several hydrophobic interactions between TMHII of each 
respective molecule, where Leu240, Leu241, and Ile244 act to stabilize 
the interhelical interaction (Fig. 1C). It is evident that TMHII is a 
key player in maintaining the AxqNOR dimer, and its importance is 
discussed in more detail below. In contrast, GsqNOR and NmqNOR 
were considered to be monomers in the crystal structure. Although 
inactive monomeric GsqNOR is present in the asymmetric unit, a 
reexamination of the high-resolution crystallographic structure by 
PISA (Protein Interfaces, Surfaces and Assemblies) (33) shows that 
it also probably forms a dimer in the crystal lattice (Fig. 2A), 
preserving the helical interface. In addition, GsqNOR shows a number 
of residues on the periplasmic helical region that could also contribute 
to the dimeric interface (Fig. 2B). The equivalent region in AxqNOR 
revealed no such favorable interactions (Fig. 2C), despite the fact 
that the dimer interface area is similar to that in GsqNOR (2278 Å2 
versus 2237 Å2, calculated by PISA). However, several charged residues, 
such as Arg120 and Glu121, may interact at some point, despite the 
lack of Glu121 side-chain density (Fig. 2D). The oligomeric status of 
active NmqNOR was assessed by obtaining a cryo-EM dataset of 
wild-type NmqNOR. The data produced a 9 Å resolution structure, 
indicating the enzyme to be a dimer (fig. S1).
Catalytic site arrangement reveals altered  
glutamate conformation
The arrangement of the metal centers, namely, the electron-accepting 
heme b, the propionate bridging Ca2+, and the binuclear center of 
heme b3 and FeB, is largely similar to those of GsqNOR and 
NmqNOR, aside from the heme b3 iron to FeB distance. The densities 
of heme b3, FeB, and their respective ligands (His486, His537, His538, 
and His629) are well defined, where additional conserved residues 
(Tyr638 and Gly603) provide structural support to Glu490 and His629, 
respectively (Fig. 3A). Previous structures of active NORs, including 
cNOR, have shown the heme b3 Fe to FeB distance to be between 3.2 
and 3.9 Å [for NmqNOR (20) and Pseudomonas aeruginosa cNOR 
(PacNOR) (5), respectively], whereas in AxqNOR, the distance is 
4.1 Å. In GsqNOR, the distance was 4.8 Å, albeit with zinc instead of 
iron and with the heme b having been reduced by x-ray exposure 
(Fig. 3B). An important area of ambiguity in previous structures of 
qNORs was the side-chain orientation of Glu490 (Glu512 in GsqNOR) 
because zinc was found in the GsqNOR structure (rendering it inactive) 
and side-chain density could not be resolved with the NmqNOR 
structure. In PacNOR, the corresponding residue Glu211 ligates the 
nonheme iron, while in GsqNOR, it is not a ligand for zinc. The 
AxqNOR structure contains the correct nonheme metal at the binuclear 
center (FeB), but the density for the carboxyl group of Glu490 suggests 
a different conformation for the side chain compared to GsqNOR 
and PacNOR, with the carboxyl group approximately 3.5 Å from the 
His486 NE2 atom (Fig. 3, C and D). This may reflect a genuine difference 
in proton delivery pathways between the qNOR (as represented by 
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the structure of active AxqNOR) and the cNOR (as represented by 
the structure of active PacNOR) because the latter receives protons 
from the periplasm via Glu280 (Glu559 in AxqNOR) (5).
A 3.2 Å structure of an activity-enhanced Val495Ala 
in AxqNOR
An analysis of residues believed to be functionally important in 
qNORs (vide infra) in the context of the cryo-EM structure of wild-
type AxqNOR was done to design and test a number of mutants. 
One of the mutants, Val495Ala, revealed an enhanced activity (by 
twofold) compared to wild type and was thus chosen for cryo-EM 
structure determination. A total of 227,000 particles were used in 
the final refinement (C2 symmetry), with a global resolution of 
3.3 Å and a local resolution at 3.2 Å. Upon docking the wild-type 
EM model into the map, the mutation was clearly visible (Fig. 4A). A 
notable difference was the poor density of Glu494 side chain, which, 
in the wild-type AxqNOR, was resolved to be facing toward Asn600, 
forming a hydrogen bond (Fig. 4A). The Val495Ala mutation appears 
to have increased conformational flexibility of Glu494. However, the 
overall structure of Val495Ala-BRIL is largely similar to that of the 
wild type, with some additional density between the dimer interface 
assigned as detergent molecules, which were used in solubilization 
[dodecyl maltoside (DDM)]. The density for the saccharide portion 
was clear for only half of the molecules and was left for visualization. 
These molecules are stabilized by Val230 and His224 of TMHII (seen 
in multiple conformations). Val615 of TMHXI from the opposing 
molecule also interacts with the acyl tail of the detergent, providing 
a way to stabilize the dimer interface (Fig. 4B). Density, which 
appeared to be phospholipid-like, was also seen near the dimer 
interface, with one phosphatidylethanolamine molecule providing 
an anchor between TMHII of one molecule and surrounding helices 
of the other molecule through Phe598 and Phe680 (Fig. 4C). In addition, 
a lipid molecule (truncated to fit the density) was seen closer to the 
periplasmic surface, where His692 potentially interacts between the 
phosphate head group and the acyl tail of the lipid, and also Met231 
of TMHII in proximity to the acyl tail (Fig. 4D).
Water-mediated proton transfer in AxqNOR
As a result of the improved resolution of the structure of the Val495Ala 
mutant, several new features could be resolved; most notably, a 
number of water molecules lining the polar channel from the cyto-
plasmic side to the binuclear site could be seen (Fig. 5A). Several 
mutants were thus generated on the basis of both sequence conser-
vation (fig. S4) and known structural data, which were then tested 
for NO reduction under anaerobic conditions. Metal content analysis 
showed that all mutants had a minimum of 60% of Fe compared to 
wild type, with optical spectra of most mutants in the Soret region 
[maximum absorbance at 410 nm (A410)] in the oxidized state, 
indicative of a nonperturbed heme environment (fig. S5). A410/A280 
ratios of mutants ranged from 0.73 to 0.80 (wild type at 0.70). A 
closer examination of a residue near the proposed proton entry site 
(Arg255) reveals a water molecule between Glu572 and Arg255, which 
may act as a proton entry point. Glu572Ala had a slightly enhanced 
activity compared to the wild type, which, considering its proximity 
to a water molecule and Arg255, was unexpected. Both Arg255 and 
Glu572 show relatively weak conservation among qNORs (fig. S6), 
although a charged residue usually resides in these positions. This 
may explain why Glu572Ala mutants showed little change in NO 
reduction activity, or it may be that Glu572 is bypassed during proton 
transfer. The sequential triple mutant in the aforementioned region 
(Lys257Ala-Glu258Ala-Glu259Ala) revealed similar consumption rates 
to the wild-type enzyme, ruling out any significant involvement of 
these residues in proton entry. Glu258 and Glu259 were not observed 
in the map for wild-type AxqNOR, although the main chain could 
be resolved in the mutant map. Mutation of the highly conserved 
Tyr638 to Phe, which provides structural support to the Glu490 backbone 
carbonyl oxygen, did not severely affect the activity. In contrast, muta-
tions of a number of residues located between the middle of the hydro-
philic channel and the active site resulted in a substantial loss of 
activity. Ser523, with a conservation of ~30%, showed a ~70% loss of ac-
tivity (Fig. 5B) upon mutation to alanine, which we suggest arises from 
the loss of a water molecule that may pass through the flexible Glu569 
(mutants of which we could not express) and Ser523. Mutations of 
Fig. 1. Overall structure of AxqNOR and interhelical dimer interactions. (A) Dimeric AxqNOR in plane of the lipid bilayer (orange lines) colored by chain (A in teal and 
B in maroon), with heme groups denoted as purple and cyan sticks. (B) AxqNOR viewed from the periplasmic side showing transmembrane helices numbered with roman 
numerals, with heme and nonheme iron (FeB) ligating histidines shown as sticks. Calcium is shown as green spheres, and FeB is shown as red spheres. (C) Hydrophobic 
interactions between TMHII of each respective Val495Ala molecule with the density map contoured at 7 around the residues, with the wild-type exhibiting a consistent 
arrangement.
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Glu490, Glu494, and Asn600 (based on sequence alignment of 224 
qNOR sequences; the former is fully conserved, while the latter two 
are 99%, possibly from alignment inaccuracies due to varying gaps) 
resulted in over 90% loss of activity, providing evidence of their 
importance in qNOR functionality. The oxidized optical spectra of 
S523A were slightly perturbed at the Soret region, with absorbance 
at 411 nm (fig. S5). These are positioned along the proton delivery 
channel to the active site, where one of the glutamates, Glu494, interacts 
with Asn600 by a hydrogen bond in the wild-type structure (Fig. 5C). 
Glu494 in the 3.3 Å AxqNOR-Val495Ala structure exhibits a loss of 
density, with Asn600 maintaining its position, yet no water molecules 
were found in the vicinity. The results of the Glu494 mutation are 
consistent with a previous observation that the corresponding residue 
in NmqNOR was important for proton delivery (20). A water 
molecule was found ligating the carboxyl group of Glu490 and Glu559 
(the higher-resolution AxqNOR-Val495Ala structure provides clear 
density of Glu559), which is not the case in GsqNOR, as this water 
does not ligate to the equivalent residues Glu512 and Glu581 (Fig. 5D). 
The loss of activity for Glu490Ala variant in AxqNOR, likely due to 
the loss of the water molecule and thus the proton source, is consistent 
with GsqNOR Glu512Ala (18), although whether the Glu512 ligates 
water in the active state is not known. Overlaying the GsqNOR 
water channel region with AxqNOR-Val495Ala equivalent region 
shows a more continuous “chain” of waters in the higher-resolution 
(2.5 Å) GsqNOR structure (Fig. 5E). Several waters are in proximity 
to those found in GsqNOR, namely, between Glu572 and Arg255, 
Glu569 and Thr498, and Glu490 and Glu559, providing support to the 
idea that AxqNOR probably uses protons from the cytoplasmic side 
for catalytic NO reduction.
A putative substrate access channel
We conducted a search of potential channels within our AxqNOR 
structures using CAVER (34) to reveal whether any relevant channels 
could pertain to substrate entry and delivery to the active site. Starting 
the search from the active site, three potential candidates were 
found to be plausible (Fig. 6, A and B), two of which pass by Val485 
Fig. 2. Comparison of qNOR dimers and potential soluble interface interactions. (A) Alignment of AxqNOR (teal) and the dimeric GsqNOR assembly (purple) via 
PISA. The structures align relatively well despite an overall RMSD of 2.35 Å; dimer mediating TMHII of GsqNOR and AxqNOR are colored in red and gold, respectively. 
(B) Potential interactions between the GsqNOR monomers in the dimer, as determined by PISA, shown from the periplasmic side, with residues shown as purple sticks. All 
interactions are ≤4 Å in bond length. Most of the interactions could occur via a periplasmic helical region, with Glu229 and Lys714 located on TMHIX and TMHX of opposing 
molecules, respectively. (C) Equivalent residues in AxqNOR (mutant structure) contoured with density at 5 showing no feasible interactions. (D) Potential interactions 
between Arg120 and Glu121 of opposing AxqNOR molecules, where the density was contoured at 4 for the side chains and the Glu121 side chain could not be resolved.
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(~7 Å from FeB) en route to the active site from the bilayer. Given the 
knowledge that Val206 in PacNOR is implicated in NO transport and 
is found in the same spatial position as Val485, we mutated Val485 to 
alanine to ascertain whether it can facilitate NO transport or inhibit it. 
The Val485Ala mutant of AxqNOR exhibited a ~70% loss of activity, 
signifying its role in NO delivery. The substitution to a smaller side 
chain may be expected to widen the channel, potentially allowing less 
constraint for NO to access the catalytic site. Yet, the Val206Trp 
mutant of PacNOR caused loss of NO consumption in vitro, which is 
suggested to be due to the increase in bulk, creating a barrier near the 
active site (35). Having a residue of sufficient hydrophobicity and ap-
propriate size is a key component in determining NO access to the 
active site. Closer inspection of the structure showed that the highly 
conserved Val489 (fig. S4) lies beneath Val485, which may act in tandem 
with Val485 to funnel NO toward the active site. GsqNOR channel 
analysis revealed two channels that overlap a similar spatial location in 
AxqNOR, which may indicate a conserved role of these hydrophobic 
tunnels in substrate transfer (Fig. 6C). Comparison with structures of 
PacNOR [and its complex with cd1NiR (35)] and Thermus thermophilus 
cytochrome ba3 (36) suggest that similar hydrophobic channels exist 
for gas diffusion from outside the membrane to the active site.
DISCUSSION
Highly active preparations of AxqNOR were obtained but did not 
yield well-diffracting crystals <7 Å, despite substantial efforts. Given 
a relatively small MW of the monomer (~85 kDa) for cryo-EM ex-
periments, it was fused with apocytochrome b562 [BRIL(30)], raising 
the MW of the monomer to ~96 kDa. This facilitated structural deter-
mination by cryo-EM, unexpectedly revealing a dimeric AxqNOR 
(predicted MW with BRIL, ~190 kDa). The high quality of the 
structures suggests that BRIL may have also stabilized AxqNOR, 
something often seen in the crystallographic structure determination 
of G protein (heterotrimeric guanine nucleotide–binding protein)–
coupled receptors (37). Attachment of BRIL at the C terminus of 
AxqNOR (TMHXIV) did not alter the enzymatic activity. Despite the 
high quality of maps, BRIL could not be resolved to high resolution, 
although it is clear from both the 2D classes and 3D reconstruction 
that its spatial location is well away from the dimer interface and it 
displays a large degree of flexibility (fig. S2). The resolution obtained 
here compares favorably against complexes of larger sizes, using a 
similar number of particles in the final refinement (52,000 to 57,000), 
e.g., cytochrome bc1 (~500 kDa, 4.4 Å) (38) and alternative complex 
III (~316 kDa, 3.9 Å) (39). The Val495Ala-BRIL mutant provided a 
structure at a higher resolution of 3.3 Å using 227,000 particles, with 
local resolution estimates from ResMap (40) ranging to as high as 
2.5 Å (fig. S3).
The dimeric structure of a qNOR observed here raised an im-
portant question regarding the oligomeric status of the functionally 
important form of the previously crystallographically studied qNORs. 
A cryo-EM data collection of wild-type NmqNOR provided a 9 Å 
structure demonstrating it to be dimer, suggesting that crystallization 
Fig. 3. Active-site configurations in NORs. (A) Binuclear center and corresponding density of AxqNOR with FeB (red sphere) coordinated by His486, His537, and His538, 
where Glu490 facing away from FeB with calcium (green sphere) is ligated by heme b and heme b3 propionates, Glu407, Try78, and Gly76 (the latter three residues are highly 
conserved in qNORs). Tyr638 and Gly603 provide additional structural support to the Glu490 backbone carbonyl oxygen and His629 ND1 atom, respectively. (B) Binuclear 
center of GsqNOR with zinc and water molecules shown as gray and red spheres, respectively. (C) Comparison of side-chain conformations (numbered according to 
AxqNOR) viewed from above the binuclear center in AxqNOR (teal), GsqNOR (purple), and PacNOR (yellow). Zinc is shown as a gray sphere, while FeB is colored red. 
(D) Zoomed-in view of the binuclear center, highlighting the Glu490 orientation of GsqNOR, AxqNOR, and PacNOR, colored as in (C).
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may have preferentially selected the monomeric species. Both AxqNOR 
cryo-EM structures show that TMHII, which is absent in cNORs, 
maintains the dimeric form of AxqNOR with several hydrophobic 
interactions between TMHII of each respective molecule, acting to 
stabilize the interhelical interaction. Lipids are known to facilitate and 
be indispensable for oligomerization and functioning of several mem-
brane protein complexes [e.g., leucine transporter (41), cytochrome c 
oxidase (42), and cytochrome bc1 (43)]. The presence of lipids around 
the dimer interface may be a key physiological feature in qNORs, and 
the presence of detergent at the dimer boundary might be a surrogate 
for host lipids, because the hydrophobic residues on TMHII and 
Val615 from the opposing molecule interacted with the acyl tail and 
could conceivably do so with lipids. Because monomeric qNOR is 
also isolated during purification, the addition of detergent may re-
place some weakly bound lipids, which may alter the dimer affinity, 
causing a greater propensity of monomers or preferential selection 
during crystallization conditions. The absence of monomers in the 
cryo-EM data suggests that dominant species of active AxqNOR 
and NmqNOR, from which EM grids were made, is dimeric.
Although the replacement of nonheme FeB with zinc in GsqNOR 
hampered the elucidation of a structure-function relationship in 
qNOR, comparing the structure of inactive GsqNOR with that of 
active AxqNOR provides valuable information in reaching the 
structure-property relationship that is generic for qNORs. A proton 
entry site for qNORs has been proposed to be on a cytoplasmic loop, 
composed of several charged residues. Our triple mutant (Lys257-
Glu258A-Glu259A) had a similar activity to the wild type, which was 
similar in the case of NmqNOR with the Glu259 point mutations. 
The enhanced resolution for AxqNOR from the structure of the 
Val495Ala-BRIL mutant has allowed us to map out a number of water 
molecules, with Arg255 potentially acting as a starting point for proton 
transfer from the cytoplasmic solvent toward the binuclear site. The 
significantly enhanced activity of Val495Ala is likely to arise from 
alleviating proton transfer as the rate-limiting step. This most likely 
results from increased conformational dynamics of Glu494, which 
shuttles the proton toward the catalytic pocket. The importance of 
several residues located between the binuclear center and the cyto-
plasmic surface is indicated in this study, namely, Ser523 and Asn600, 
in maintaining a putative proton transfer channel with possible 
partners Glu569 and Glu494, respectively. Ser523, despite its relatively 
low conservation (30% among 224 sequences), exhibits a significant 
loss of activity upon mutation. The conformer of Glu569 is facing 
Fig. 4. Val495Ala-BRIL structural features and lipid-protein interactions. (A) Insight into the structural impact of the Val495Ala mutation on the orientation of Glu494: left, 
density for Val495Ala contoured at 4 with Glu494 side chain not visible in the density map; middle, wild-type structure density contoured at 4 (Glu494-Asn600 salt bridge 
shown in black); right, aligned structures highlighting the differences between side-chain orientations (wild type in teal and Val495Ala in pink). (B) The possible truncated 
DDM molecule (depicted as green stick) at the dimer interface, mediated by His224, is shown in two conformations near the detergent head group, while highly conserved 
valine residues on TMHII (Val230 and Val237) and Pro613 from the opposing molecule (TMHXI) may stabilize the acyl chain. Symmetry-related DDM is not shown for clarity. 
(C) Phosphatidylethanolamine (PE) molecule, shown as a yellow stick, found toward the cytoplasmic end of the protein, with the acyl tail running close to TMHII residues 
(Val238, Leu246, and Ala250) of one qNOR chain (in blue) and Phe598 and Phe680 of another chain (in pink). (D) PE molecule (yellow stick) found on the periplasmic side of the 
dimer interface, stabilized by Met231 of TMHII, with His692 interacting electrostatically with the propionate group.
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toward Ser523 in our structures, which may indicate a functional role 
of Glu569-Ser523 in proton transport. The drastic effect on activity 
due to the mutation of Glu494 in both AxqNOR and NmqNOR (Glu498) 
suggests its critical functional role in qNOR. However, the equiva-
lent mutant in Paracoccus denitrificans cNOR (Glu202) shows only 
~60% loss of activity when heterologously expressed in Escherichia 
coli JM109 cells (44, 45), consistent with its potential role in provid-
ing a sufficient electronegative environment to lower the redox 
potential of the heme b3 iron compared to the other heme groups 
(46). It should be noted that Glu490 and Glu494 variants in AxqNOR 
exhibited ~70% of Fe compared to wild type. This may contribute to 
a lower activity, but the oxidized and reduced optical spectra of all 
variants were identical to those of wild type (fig. S5), suggesting that 
iron is not depleted from the FeB site preferentially. Contrary to 
cNOR, proton transfer pathway in qNORs likely originates from the 
cytoplasmic side, with Glu494 playing an important part in proton 
transport.
The mechanism of NO reduction in membrane-integrated NORs 
has been the subject of intense investigation, and the structural de-
termination of PacNOR was a significant step. A key element was 
the proposed flexibility of Glu211 (coordinating FeB) to accommodate 
two NO molecules in the active site. Glu211 (Glu490 in AxqNOR) is 
proposed to accept protons from Glu280 (Glu559 in AxqNOR), causing 
protonation and possible dissociation from FeB, allowing NO binding 
Fig. 5. Putative water channel in AxqNOR and effects of mutagenesis on NO reductase activity. (A) Residues [colored labels according to bar graph in (B), with the 
exception of Asn600 and Glu490] and accompanying densities lining the proposed proton transfer in Val495Ala AxqNOR (pink sticks) from the cytoplasmic side to the binuclear 
center (calcium and FeB are shown as green and red spheres, respectively). Water molecules are shown as yellow spheres and traverse from Arg255 toward Glu490. (B) Bar 
graph detailing the effect of structure-guided mutagenesis on NO reduction rates, performed in anaerobic conditions for each variant. Colored bars indicate the mean 
consumption rate (n = 3), with SEM bars shown for each variant as black lines. (C) Alignment of the wild-type AxqNOR (teal sticks) and Val495Ala proton transfer pathway 
indicating the variation in some side-chain conformations, notably with Glu572 and Glu494. (D) Comparison of the binuclear site among wild-type AxqNOR (teal), Val495Ala 
AxqNOR (pink), and GsqNOR (purple), with residue numbers from AxqNOR. Calcium is shown as a green sphere, FeB in wild-type AxqNOR is shown as an orange sphere, 
and FeB in Val495Ala AxqNOR FeB is shown as a red sphere. Water molecules from Val495Ala are depicted as yellow spheres, while those from GsqNOR are shown in blue. 
Waters bridging the nonheme metal to the heme b3 (oxo ligand) and in between Glu490 and Glu559 show similar locations in both GsqNOR and Val495Ala AxqNOR structures. 
(E) GsqNOR water channel (residues in purple sticks, water shown by gray spheres) aligned against Val495Ala AxqNOR equivalent region (residues in pink, water shown as 
yellow spheres). Residues show higher conservation further up the channel, with GsqNOR having a continuous chain of water molecules toward the binuclear site.
 o
n
 Septem
ber 6, 2019
http://advances.sciencem
ag.org/
D
ow
nloaded from
 
Gopalasingam et al., Sci. Adv. 2019; 5 : eaax1803     28 August 2019
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
8 of 11
[assuming that an increase in the Fe-Fe distance to at least 4.4 Å oc-
curs, as suggested by Richardson and colleagues (2)], while structures 
of the ligand analog–bound forms of PacNOR showed that Glu211 co-
ordinated to FeB even in the presence of the ligand. Glu490 in AxqNOR 
unequivocally faces away from FeB, suggesting that Glu490 and its 
equivalents in (active) qNORs do not act as an FeB ligand and instead 
ligate a water molecule along with Glu559. The directionality of proton 
transfer to the terminal glutamates in qNOR differs from cNOR, as 
Glu494 in AxqNOR is crucial to activity but the equivalent glutamate in 
cNOR only loses half its activity when mutated (44), possibly down to 
periplasmic supplied protons flowing through Glu280 toward Glu211. 
The precise role of this residue in cNOR is still unclear. It has been 
suggested that it may be a remnant in the evolutionary pathway in 
acquiring protons from the cytoplasmic end in cytochrome oxidases 
because it is (roughly) positioned at the end of the K pathway (47).
Molecular dynamic simulations of the crystal structure of 
PacNOR-cd1 NiR complex suggested that NO transfer may occur 
primarily via the lipid bilayer and not via the active sites of each 
enzyme (35). Given the lipophilicity of NO, the migration of NO 
toward and into the lipid bilayer is feasible. Depending on where 
AxNiR may interact (with either AxqNOR, the lipid bilayer, or both), 
the use of either channel seems plausible for providing access to NO 
released from AxNiR. We identified Val485 to be an important residue 
in guiding NO to the active site of AxqNOR, but as the Val485Ala 
mutant exhibited a loss of 70% activity, additional inputs may be 
present. In view of the need to detoxify NO rapidly, having multiple 
entry points may be an advantage. The passage of NO and its binding 
to qNOR may also need to be barrier-less, consistent with a fast rate 
constant as established in cNOR (48). The tunnel analysis suggests 
that Leu376 and Phe420 may act as input points, yet the intersections 
of the tunnels before the active site consist of Val485 and Val489. Be-
cause Val489 is strongly conserved (fig. S6), it may compensate for 
the loss of Val485 to continue shuttling NO. A computation study on 
PacNOR investigated NO diffusion and found that several migration 
pathways exist (termed dominant and alternate), where migration 
of NO is ~10-fold lower using the alternate route than using the 
dominant pathway (49). Several of the routes include conserved resi-
dues found in our tunnel analysis (Val285, Ile484, Leu336, and Leu487), 
which may suggest a generic role in NO transport across NORs. A similar 
study on cytochrome ba3 found hydrophobic tunnels that are located 
within the bilayer and provide O2 an area to partition from the aqueous 
phase, with no significant energetic barriers for O2 transport (50).
In summary, we solved the structure of wild-type and mutant 
AxqNOR at local resolutions of 3.7 and 3.2 Å, respectively, by cryo-EM. 
These structures are the first example that documents dimeric struc-
tures of qNORs, providing details on the structural architecture. 
The active site and putative proton transfer pathway arrangements 
are revealed at a high enough resolution of an active qNOR. The 
current structure and mutational results, together with the previous 
data, suggest that qNORs take up protons from cytoplasmic side, 
with several water molecules facilitating this to occur. This is in 
contrast to cNORs, which receive protons from the periplasmic side 
(5). This redefines the role of qNOR as a respiratory enzyme, and its 
evolutionary relationship to cytochrome c oxidase, setting qNORs 
apart from both cNOR and the denitrification enzymes NiR and 
nitrous oxide reductase, which are not considered to be directly in-
volved in energy conservation.
MATERIALS AND METHODS
Construction of AxqNOR-BRIL expression plasmid and  
site-directed mutants
The AxqNOR-BRIL and Val495Ala-BRIL expression plasmid was 
made by GenScript (Hong Kong), with the AxqNOR gene (NorZ) 
truncated (747 to 763) to accommodate the apocytochrome b562 
[BRIL562, Protein Data Bank (PDB) accession code: 1M6T] fusion 
partner at the C terminus of AxqNOR. The chimeric gene (qNOR-BRIL) 
was then ligated between the Nde I and Xho I sites of a pET-26b (+) 
plasmid, allowing a hexa-histidine tag to be attached at the C terminus 
of BRIL562. Site-directed mutants of qNOR were generated using the 
QuikChange II Kit (Agilent) using the wild-type AxqNOR plasmid as 
a template vector. Mutations were confirmed by DNA sequencing 
before use.
Purification of AxqNOR-BRIL, Val495Ala-BRIL, and  
site-directed mutants
C41 (DE3) E. coli cells (Lucigen) were transformed with the expression 
plasmid and grown in 2xYT media. Upon reaching an A600 of 
Fig. 6. Putative NO diffusion pathways in wild-type AxqNOR. (A) Location of proposed hydrophobic channels in wild-type AxqNOR protruding from the bilayer to the 
binuclear site, based on CAVER analysis, shown as blue, yellow, and pink tunnels. (B) Location of hydrophobic channels viewed from the periplasmic side lined with resi-
dues situated along the tunnels (heme groups are shown as teal sticks, with calcium and FeB shown as green and red spheres, respectively). Val485 and Val489 are colored 
in pink and purple sticks. (C) GsqNOR hydrophobic tunnels [from Matsumoto et al. (18)] with residue numbers from AxqNOR (teal) and GsqNOR (purple) aligned, showing 
similar spatial location and residue type, with Val485 being replaced with Ile507 in GsqNOR.
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~2, ∂-aminolevulinic acid (Sigma-Aldrich) and FeCl3 were added at 
final concentrations of 200 M, as well as IPTG (isopropyl-- 
D-thiogalactopyranoside) was added at a final concentration of 
500 M, to induce overexpression of qNOR-BRIL. Harvested cells 
were washed in 50 mM tris (pH 7.0) and 150 mM NaCl and then 
lysed by sonication, before collecting membrane fractions by ultra-
centrifugation. Membranes (final concentration of 7 mg/ml) were 
solubilized in 50 mM tris (pH 7.0), 150 mM NaCl, and 1% (v/v) 
-DDM (Anatrace) for 2 hours at 4°C. The solubilized material was 
separated by centrifugation at 40,000 rpm and loaded onto a pre- 
equilibrated 5-ml HisTrap column (GE Healthcare). The column 
was subjected to three column volumes worth of washing in 50 mM 
tris (pH 7.0), 150 mM NaCl, 20 mM imidazole, 0.05% DDM, and 
then two-column volumes in the same buffer, yet with 35 mM im-
idazole. The protein was eluted in the same buffer, using 150 mM 
imidazole instead. Fractions were assessed for purity by SDS–
polyacrylamide gel electrophoresis and ultraviolet (UV)–visible 
spectroscopy (U-3300, Hitachi), with elutions having an A410/A280 
ratio of >0.6 being carried forward. After concentration in Amicon 
Ultra 100K concentrators, qNOR-BRIL was loaded onto a Superdex 
200 10/300 Increase (GE Healthcare) column equilibrated in 50 mM 
tris (pH 7.0), 150 mM NaCl, and 0.05% (v/v) decyl-thio-maltoside 
(DTM) (Anatrace). Fractions with A410/A280 > 0.7 were concentrated 
to 20 mg/ml and flash-frozen in liquid nitrogen, before storage at 
−80°C. Val495Ala-BRIL was purified in the same manner, except that 
buffers were at pH 7.5. Site-directed mutants were purified in a similar 
manner to AxqNOR-BRIL, except that, at gel filtration, 0.05% DDM 
was used instead of DTM.
UV-visible absorption spectroscopy
Absorption spectra were recorded on U-3300 spectrophotometer 
(Hitachi). AxqNOR samples were diluted in gel filtration buffer and 
subjected to measurements for the oxidized state. An excess of sodium 
dithionite was added to the oxidized samples (final concentration, 
~1 mM) and remeasured to obtain fully reduced spectra.
Enzymatic activity measurements
Before enzyme activity measurements, samples were subjected to 
inductively coupled plasma optical emission spectrometry (ICP-OES) 
analysis with an ICP-OES 5110 instrument (Agilent) to ascertain 
metal content. qNOR activity was measured using a Clark-type 
electrode fitted with an ISO-NO Mark II system (WPI). All reaction 
components (aside from glucose oxidase and catalase) were made 
anaerobic by replacing the atmosphere of the vials with N2. The 
assay buffer contained 50 mM Na-citrate (pH 6.0), 0.05% DDM or 
DTM, 100 mM d-glucose, 10 g ml−1 glucose oxidase, and 10 g ml−1 
catalase. Glucose, glucose oxidase, and catalase were added to scavenge 
any oxygen left in the reaction vessel. Sodium ascorbate (1 mM) 
and phenazine methosulfate (10 M) acted as an electron donation 
system. A 2 mM NO saturated solution [50 mM Na-citrate (pH 6.0)] 
was made and added at a final concentration of 20 M. NO con-
sumption was started by addition of the protein at a final concentra-
tion of 0.2 M.
Cryo-EM sample preparation and data collection
qNOR-BRIL was diluted to 3 mg/ml, and 3 l of aliquots was applied 
on glow-discharged Quantifoil Au R1.2/1.3 holey carbon grids. Grids 
were plunge-frozen in liquid ethane using Vitrobot Mark IV (FEI), 
with grids blotted for 6 s, and a blot force of 6, maintained at 100% 
humidity and 4°C. Grids were then loaded into an FEI Titan Krios 
TEM (Astbury Biostructure Laboratory, University of Leeds), operat-
ing at 300 kV, equipped with a K2 Summit detector (Gatan). Auto-
mated data collection was performed with EPU software at a 
magnification of ×75,000, using a defocus range of −1.5 to −3.5 m. 
A total of 3213 micrographs were collected with a pixel size of 1.07 Å. 
A total dose of 65 e−/Å2 was acquired by using a dose rate of 6.21 e− 
pixel−1 s−1 across 40 frames for 12 s of total exposure time. AxqNOR 
Val495Ala-BRIL was prepared in the same way as the wild type, except 
that the sample (5 mg/ml) was used with Quantifoil Cu R1.2/1.3 
holey carbon grids. Val495Ala-BRIL grids were loaded into an FEI 
Titan Krios at Electron Bio-Imaging Centre (eBIC) (Diamond Light 
Source) operating at 300 kV, equipped with a K2 Summit detector 
(Gatan). Automated data collection was performed with EPU soft-
ware at a magnification of ×47,710, using a defocus range of −1 to 
−3 m. A total of 1803 micrographs were collected with a pixel size 
of 1.05 Å. A total dose of 49 e−/Å2 was acquired by using a dose rate 
of 4.16 e− pixel−1 s−1 across 40 frames for 10 s of total exposure time.
Image processing
All image processing was performed in RELION 3.0(51). Beam- induced 
motion and drift correction were performed using RELION 3.0 own 
implementation. Contrast Transfer Function (CTF) estimation was 
carried out using CTFFIND-4.1 (52), with CTF correction carried out 
on non–dose-weighted micrographs, with further data processing done 
on dose-weighted micrographs. Around 2000 particles were manually 
picked and extracted to generate initial 2D classes that were used 
as templates for automatic particle picking. Approximately 700,000 
particles were picked and sorted before 2D classification on ~540,000 
particles was carried out. The best 2D classes were chosen to make 
an initial model, which was then low pass–filtered to 60 Å and used 
for 3D classification. Several rounds of 3D classification were per-
formed, with the best class out of three being taken forward for the 
next round of classification. A total of 56,134 particles yielded a 
refined map at a global resolution of 4.1 Å with C2 symmetry, using 
a soft mask encompassing the protein and detergent micelle. CTF 
refinement and Bayesian particle polishing improved the resolution 
to 3.9 Å, where local resolutions suggest that the core of the protein 
is 3.7 Å. Tighter masks failed to increase the resolution of the final 
map. Resolutions were estimated by the gold standard FSC = 0.143 
criterion, while local resolutions were valued using RELION. Val495Ala 
was processed in a similar fashion to the wild type, albeit with 
motion correction carried out using RELION 3.0 implementation. 
From ~600,000 auto-picked particles, multiple rounds of 2D and 3D 
classification led to 227,000 particles being used in the final recon-
struction to attain a resolution of 3.7 Å, with C2 symmetry. After 
CTF refinement and Bayesian particle polishing, the resolution im-
proved to 3.5 Å. A tight mask excluding the micelle was used in 
postprocessing to improve the resolution further to 3.3 Å, with a 
local resolution at 3.2 Å. Resolutions were estimated by the gold 
standard FSC = 0.143 criterion, while local resolutions were valued 
using RELION. ResMap (40) was used to assess slice through volume 
local resolution estimates.
Model building, refinement, and validation
The high-resolution GsqNOR (PDB accession code: 3AYF) structure 
(33% sequence identity) was fitted into the locally filtered map us-
ing the Chimeras “Fit in Map” function (53), which then served as 
a template to manually build the AxqNOR structure in Coot. The 
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Arp/Warp web server (https://arpwarp.embl-hamburg.de/) was used 
as an additional aid in manual model building in difficult regions 
(solvent-exposed loops and periplasmic helical region). As the 
density of the BRIL was far less detailed than that of the qNOR 
molecules, only qNOR was built into the maps. The resulting structure 
was then refined with secondary structure and custom geometry 
restraints around the metal centers (heme b, Ca2+, heme b3, and FeB) 
and their respective ligands, using the phenix.real_space_refine 
program in the Phenix suite (54). Models were checked in Coot to 
identify any regions that needed correcting, based on both Coot and 
MolProbity validation statistics. For Val495Ala, B-factor sharpening 
was performed on the local resolution filtered map, using a value of 
−147 Å2, determined from running the bfactor_plot.py script in 
RELION 3.0. The structure of Val495Ala was solved by fitting the 
wild-type AxqNOR model into the map and adjusting/refining 
the model as described before. Figures were made using Chimera 
and PyMOL.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/5/8/eaax1803/DC1
Fig. S1. 3D cryo-EM reconstruction of wild-type NmqNOR.
Fig. S2. Summary of cryo-EM data collection for wild-type and Val495Ala AxqNOR.
Fig. S3. Henderson-Rosenthal plots of qNOR datasets and local resolution slice through plots.
Fig. S4. Multiple sequence alignment of selected qNORs.
Fig. S5. Oxidized and dithionite reduced spectra of selected AxqNOR variants.
Fig. S6. Residue probability chart of qNORs.
Table S1. Cryo-EM data collection parameters and refinement statistics.
Table S2. AxqNOR putative proton transfer channel site-directed mutants’ conservation and 
relative activities.
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